PA-BOOMI
Boomi™, the intelligent integration and automation leader, is thrilled to announce Boomi World is back. The company’s highly anticipated industry event will take place May 6-9, 2024 at the Sheraton Denver Downtown Hotel in Denver, Colorado. Boomi World 2024 promises to be a transformative experience, bringing together industry leaders, technology experts, and visionary professionals to explore the latest trends and innovations in AI, integration, and automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240409873041/en/
Boomi World 2024 User Conference to Feature Deion “Coach Prime” Sanders (Graphic: Business Wire)
Emceed by technology industry veteran and correspondent Lisa Martin, Boomi World 2024 will feature esteemed guest speakers, including:
- Collegiate Head Football Coach and Pro Football Hall of Famer Deion Sanders
- Tropicana CIO Jeff Lischett
- Australian Red Cross CIO Brett Wilson
- Fever-Tree Head of Technology Kate Stables
- KORE Wireless Senior Director of Enterprise Applications Nicki Brock
- OSI Digital CMO Karen Dosanjh
- Gartner Senior Director Analyst John Santoro
- BARC US CEO Shawn Rogers
- IDC Research Director/Analyst Shari Lava
- Boomi CEO Steve Lucas
- Boomi Chief Product and Technology Officer Ed Macosky
- Boomi CTO Matt McLarty; and more!
Boomi World 2024 will provide attendees the opportunity to experience the power of AI-driven connection. Boomi’s customers and partners will discover how Boomi’s intelligent integration and automation platform helps organizations tame IT complexity, drive radical innovation, and synchronize everything, everywhere.
Event Highlights:
1. Robust Agenda
Boomi World 2024 boasts a dynamic and comprehensive agenda, featuring thought-provoking sessions, hands-on workshops, and engaging panel discussions. Attendees will have the opportunity to dive into the latest advancements in integration technology, best practices, and success stories from forward-thinking enterprises across industries that have transformed their organizations with Boomi.
2. Special Guest Deion Sanders
Boomi welcomes Deion Sanders, aka “Coach Prime,” as its special guest speaker.
As head coach from 2020-2022, Sanders led Jackson State University (JSU) to back-to-back SWAC Championships, and won back-to-back SWAC Coach of the Year honors. During his time at JSU, the Tigers had a 27-6 record, including a perfect regular season in 2022. In 2021, he was named the Eddie Robinson Coach of the Year.
Sanders is a member of the Pro Football Hall of Fame, a two-time Super Bowl champion, and eight-time Pro Bowler. He played 14 years in the NFL for the Atlanta Falcons, San Francisco 49ers, Dallas Cowboys, Washington Commanders, and Baltimore Ravens. Sanders is the only person in professional sports history to play in both the World Series and the Super Bowl.
After retiring from professional sports, Sanders became an analyst for CBS Sports and NFL Network, and now offers his insights and opinions on the Pro Football Show on Barstool Sports. He has produced and/or appeared in a variety of television shows, including Tiny House Nation, Grandfathered, Moesha, Running Wild With Bear Grylls, Lip Sync Battle, The League, 30 For 30: Deion’s Double Play, Deion’s Family Playbook, and, most recently, Coach Prime, a docuseries on Prime Video which follows Sanders and his college football journey.
3. Exclusive Announcements
Be the first to hear Boomi's latest product and platform updates, roadmap, and strategic initiatives. Boomi World 2024 will feature exclusive announcements that will shape the future of AI, integration, and automation.
4. Pre-Conference Training and Partner Summit
Starting on May 6, Boomi World will provide optional one and two-day Pre-Conference Training and certification courses, with in-depth sessions covering the various Platform Services within the Boomi platform, including Integration, runtime architecture, API Management, and Master Data Hub.
Taking place on May 7, the Boomi Partner Summit provides partners an exclusive look at the future of the Boomi ecosystem. Partners will get a sneak peek at upcoming announcements and gain access to go-to-market resources designed to drive growth while helping customers more quickly and easily connect, automate, and modernize their digital landscape.
5. 40+ Breakout Sessions
Boomi World will offer more than 40 breakout sessions focused on the following four tracks:
Hands-On Labs will offer attendees the opportunity to explore what’s new in the Boomi platform, get creative with AI, and learn about Retrieval-Augmented Generation — including how to set up a RAG using Boomi.
Developer/Technical track, which will include sessions on popular integration use cases, runtime monitoring, error-handling strategies, master data management, and “Boomi on Boomi” solutions.
CIO/Executive track for executive attendees — or anyone interested in topics designed to appeal to CIOs — which will feature sessions on risk management, Boomi platform security, and AI readiness.
Innovation track, which will include a wide range of sessions from customers, partners, industry analysts, and Boomi technology experts designed to showcase the myriad ways the Boomi platform can be used to connect and transform organizations.
6. Networking Opportunities
Connect with like-minded professionals, industry experts, and Boomi partners during dedicated networking sessions. Boomi World 2024 provides a unique platform to foster collaboration, share ideas, and build valuable relationships within the integration, automation, and connectivity community.
Sponsors:
A special thanks to Boomi’s partner sponsors for helping make Boomi World 2024 possible, including Cognizant and Infosys as Diamond sponsors, and Apica, Kitepipe, LTIMindtree, R Systems, TCS, and United Techno as Platinum sponsors.
Registration:
Registration is now open. Secure your spot at Boomi World 2024 by visiting BoomiWorld.com.
To join the Boomi World conversation on social media, use #BoomiWorld.
Additional Resources
- Learn more about the Boomi platform
- Follow Boomi on LinkedIn, X (Twitter), Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409873041/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom